November 2021 - Page 2 of 2

FridayNov 12, 2021 1:27 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Embarks on its Most Ambitious Hypertension Clinical Study Yet: HYPER-H21-4

Lexaria has embarked on its HYPER-H21-4 study, its fourth hypertension clinical study, and it's most ambitious yet This study builds on the HYPER-H21-1 and HYPER-H21-2 findings, as well as the HYPER-H21-3 study that is set to begin dosing in mid-November 2021 Lexaria’s goal is to pursue regulatory approval for its proprietary DehydraTECH-CBD for potential use as a treatment for high blood pressure Study protocols are being readied for submission to the IRB, and approval is expected by January 2022 Lexaria Bioscience (NASDAQ: LEXX) has, so far in 2021, embarked on several studies geared towards evaluating its proprietary DehydraTECH(TM) CBD for…

FridayNov 12, 2021 8:00 am

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Commences Installation of 30 Growing Pods, Produces First Batch of Chocolates at New Sanderson Production Facility

Red White & Bloom has officially entered Phase 2 of an aggressive three-phase expansion plan in Florida Phase 2 involves the installation and commissioning of 30 customized, self-contained growing pods RWB recently received OMMU approval for the first five pods that it subsequently installed and commissioned The company, through its Red White & Bloom Florida LLC subsidiary, produced the first batch of chocolates from the new Sanderson production facility, making substantial progress since launching the greenhouse facility in Apopka in late September Following the early October completion of phase one of a three-phase development strategy that captures Red White &…

WednesdayNov 10, 2021 12:14 pm

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function With neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgency InMed’s patent application is a promising start, expanding the company’s patent portfolio, which currently includes twelve patent families InMed Pharmaceuticals (NASDAQ: INM), a global leader in the manufacturing and pharmaceutical development of rare cannabinoids, recently filed a Patent Cooperation Treaty (“PCT”) application, titled…

WednesdayNov 03, 2021 1:43 pm

The Cannabis World Congress & Business Exposition (CWCBExpo) Is Set to Headline the New York Cannabis Week; Will Bring Together Hundreds of Businesses from Across the Cannabis Ecosystem

The Cannabis World Congress & Business Exposition (CWCBExpo) will be held in New York between November 4-6, 2021 The conference will feature over 50 expert speakers, in addition to hundreds of exhibitors showcasing the sector’s latest product innovations Recent forecasts have estimated overall US marijuana retail sales to rise from $20 billion in 2020 to $38.4-45.9 billion by 2025 The Cannabis World Congress & Business Exposition (“CWCBExpo”) event is set to be held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021. Set to be held during Cannabis Week, a weeklong event taking place between Monday…

WednesdayNov 03, 2021 12:37 pm

Lexaria Bioscience Corp. (NASDAQ: LEXX) Commences New Animal Study Evaluating Patented DehydraTECH(TM) Technology’s Efficacy in Reducing/Inhibiting Seizure Activity; Strengthens IP Portfolio

Lexaria recently announced the commencement of EPIL-A21-1, an animal study to evaluate whether DehydraTECH-CBD has similar or superior efficacy in reducing or inhibiting seizure activity compared to FDA-approved seizure drug, Epidiolex The study will also compare DehydraTECH-CBD to generic CBD EPIL-A21-1 has entered early-stage preparatory work, with results expected in Q3 2022 Lexaria received new patent awards in Mexico and Japan, strengthening its IP portfolio to 23 granted patents Lexaria Bioscience (NASDAQ: LEXX), the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology, recently announced it had commenced an important new animal study, EPIL-A21-1 (https://cnw.fm/iMVe3). EPIL-A21-1, which will be…

MondayNov 01, 2021 1:42 pm

Successful Ginkgo Bioworks SPAC IPO Highlights Available Industry Opportunities for InMed Pharmaceuticals Inc. (NASDAQ: INM) and Synthetic Cannabinoid Production

Special purpose acquisition company Soaring Eagle Acquisition Corp. combined with Ginkgo Bioworks to form publicly listed Ginkgo Bioworks Holdings Inc., in what is the largest-ever biotechnology go-public transaction Ginkgo Bioworks is known for its work in the commercial-scale production of a rare cannabinoid, CBG, for use in a multitude of industrial needs InMed uses multiple manufacturing approaches to synthetically produce rare cannabinoids, including CBC which is currently sold through its subsidiary BayMedica The success of the Ginkgo IPO suggests the marketplace value associated with the production of rare cannabinoids Special purpose acquisition company (“SPAC”) Soaring Eagle Acquisition Corp. (NASDAQ: SRNGU,…

MondayNov 01, 2021 11:47 am

The Cannabis World Congress & Business Exposition (‘CWCBExpo’) Establishes Itself as a Key Forum for Establishing a Foothold Within New York’s Burgeoning Cannabis Sector

New York’s recreational marijuana market is poised to begin with a bang — and the Cannabis World Congress & Business Exposition (“CWCBExpo”), which is being held at New York City’s Javits Convention Center, Hall 3A between 4-6 November 2021, is the ideal forum for education, business building and networking on this multifaceted industry. As of Sept. 21, 2021, adult New Yorkers are now able to possess up to three ounces of cannabis for recreational use or up to 24 grams of concentrated cannabis, such as oils derived from a cannabis plant (https://cnw.fm/1gF1p). With the state’s cannabis industry expected to begin…

News and publishing service for hemp related companies

Contact us: 303.498.7722

Month: November 2021